CD14 (C-159T) polymorphism is associated with increased susceptibility to SLE, and plasma levels of soluble CD14 is a novel biomarker of disease activity: A hospital-based case-control study
Article in Lupus (November 2020)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
CD14 (C-159T) polymorphism is associated with increased susceptibility to SLE, and plasma levels of soluble CD14 is a novel biomarker of disease activity: a hospital-based case-control study.
Preprint in medRxiv (June 2020)
Pattern of human monocyte subpopulations in health and disease
Article in Scandinavian Journal of Immunology (May 2020)